|
What’s Inside: Black Biotech Trailblazers Event Recap; Latest in Hematology; Salk Scientists Among Curebound Grant Winners; Take Action Against TRIPS IP Waiver; and more.
|
We’re championing the progress made by California’s life science community and want to hear about your company’s latest scientific breakthrough, investment milestone, or commitment to creating positive change for our industry. We welcome all members to submit your story here for possible inclusion in an upcoming issue. |
|
|
What’s Happening at Biocom California
|
|
Planning Ahead for JPM 2023
If you’ve attended the annual J.P. Morgan Health Care Conference in San Francisco before, you know that finding a dedicated space to connect with other business colleagues and prospects can be fairly challenging. We’re helping our members focus on forming new connections and closing important deals at this year’s JPM by providing complimentary meeting space at Hotel Zeppelin, just steps away from the conference. This exclusive membership benefit provides an ideal location to meet, network, collaborate, and hold valuable one-on-one partnering discussions. Members interested in booking meeting rooms for 30 minutes per day between January 9-12 at no charge should contact Leandra Boysen for the meeting room scheduling
assistant.
|
|
Critical Conversations with Black Biotech Trailblazers in Life Science
Last Tuesday, we had the pleasure of hosting Bay Area members at the beautiful Merck facility in South San Francisco to hear from local Black biotech trailblazers who are paving the way for a more diverse, equitable, and inclusive life science industry. Panelists Ted Love, Rahsaan Thompson, Deborah Wafer, Derrell Porter, and moderator Ronald Bolts shared some highlights and road bumps on their career journeys and offered suggestions on building company culture, advocacy, and better representation across leadership in the boardroom and on the bench. Didn’t make it to the event? Watch the full recording here.
|
|
|
Trending: The Latest in Hematology
|
|
Fake blood will be front and center this weekend before Halloween, appearing on trick-or-treaters’ costumes, in horror movies, and decor at themed “haunted” attractions. Although the sight of blood (fake or not) can be scary, the basic life-giving functions of blood in the human body–transporting oxygen and nutrients, carrying cells and antibodies that fight infections, and filtering out carbon dioxide–are often taken for granted. Blood disorders and conditions are very real: five percent of the U.S. population suffers from anemia, over 100,000 people are
living with Sickle Cell Disease (SCD), and thousands of people have hemophilia or another bleeding disorder. Recent advances in biotechnology brought a breakthrough treatment for SCD and are leading to other possible therapies for blood disorders. In this edition, we’re highlighting member companies innovating
in blood disorder treatments and diagnostics, and that are working to build up community blood supplies: Global Blood Therapeutics; BioMarin Pharmaceutical; Pfizer; Ceracor Laboratories; San Diego Blood Bank; and Sysmex America.
|
|
|
Member Moments & Industry Insight
|
|
|
|
|
Public Policy Perspective
|
|
Take Action Against New TRIPS IP Waiver
The World Trade Organization (WTO) has until December 17 to decide whether to waive intellectual property (IP) protections for COVID-19 therapeutics and diagnostics. This is a step further than the IP waiver the WTO approved earlier this year to remove IP rights for COVID-19 vaccines. Please help us protect IP rights for our industry by sending a message to the Administration and Congress to urge them to advocate against this expanded waiver.
|
Biocom California Unveils Drug Pricing Infographic
Biocom California has developed an infographic to help members visualize the new drug pricing provisions in the Inflation Reduction Act (IRA), including Medicare negotiation, Medicare Part D benefit redesign, and patient out-of-pocket caps. Help bring awareness to the harmful changes created by the IRA by sharing the infographic to your network. View our statement on the new law.
|
California Set to Become World’s Fourth Largest Economy
Despite economic setbacks, a global pandemic and an ongoing housing and affordability crisis, California is poised to surpass Germany as the world’s fourth largest economy. California continues to outperform the rest of the country and most of the world in several important industries, which feeds the state’s economic resiliency.
|
Governor Newsom Commits to Complete Second Term
In a debate between Gov. Gavin Newsom and Republican challenger, Brian Dahle, on Sunday night, Newsom pledged to complete his second term in office if reelected. Speculation about the Governor’s desire to run for President continues and it remains unclear if he will run in the coming years.
|
San Diego County CAO to Retire
Helen Robbins-Meyer, who as chief administrative officer has effectively run the San Diego County government since 2012, announced on October 12 that she will retire after 25 years working for the county.
|
South San Francisco Adopts New General Plan
On October 12, the South San Francisco City Council adopted a new General Plan and Climate Action Plan, which will guide the strategic direction of the city for the next 20 years.
|
|
|
|
Biocom California
For over 27 years, Biocom California has helped move the life science industry forward with transformative resources that enable companies to make meaningful connections. With a membership base of over 1,600 companies, we connect our members to each other so they can collaborate and work stronger and smarter together. We connect organizations to capital investment and purchasing solutions so they can grow faster and work more efficiently. We’re their link to advocacy that fights for innovation and we provide an environment where their business and talent can thrive. Biocom California is how the life science industry gets connected.
|
|
|
